(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Rubius Therapeutics, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, February 24th, 2023 | Appelhans Dannielle | officer: CEO and President | 0 | S-Sale | D | 10,385 | 0.13 USD | 1,323 USD |
| Wednesday, February 1st, 2023 | CAGNONI PABLO J | director | 66,082 | S-Sale | D | 8,448 | 0.25 USD | 2,112 USD |
| Tuesday, January 31st, 2023 | Appelhans Dannielle | officer: CEO and President | 22,500 | M-Exempt | D | 7,500 | 0.00 USD | 0 USD |
| Tuesday, January 31st, 2023 | Appelhans Dannielle | officer: CEO and President | 14,263 | M-Exempt | A | 7,500 | 0.00 USD | 0 USD |
| Wednesday, February 1st, 2023 | Appelhans Dannielle | officer: CEO and President | 10,385 | S-Sale | D | 3,878 | 0.25 USD | 970 USD |
| Tuesday, January 31st, 2023 | CAGNONI PABLO J | director | 81,770 | M-Exempt | A | 25,000 | 0.00 USD | 0 USD |
| Tuesday, January 31st, 2023 | CAGNONI PABLO J | director | 75,000 | M-Exempt | D | 25,000 | 0.00 USD | 0 USD |
| Tuesday, January 31st, 2023 | CAGNONI PABLO J | director | 74,530 | S-Sale | D | 7,240 | 0.24 USD | 1,745 USD |
| Sunday, January 29th, 2023 | CAGNONI PABLO J | director | 56,770 | M-Exempt | A | 21,250 | 0.00 USD | 0 USD |
| Sunday, January 29th, 2023 | CAGNONI PABLO J | director | 42,500 | M-Exempt | D | 21,250 | 0.00 USD | 0 USD |
| Tuesday, January 31st, 2023 | Turka Laurence A. | officer: Chief Scientific Officer | 25,875 | M-Exempt | D | 8,625 | 0.00 USD | 0 USD |
| Tuesday, January 31st, 2023 | Turka Laurence A. | officer: Chief Scientific Officer | 20,984 | M-Exempt | A | 8,625 | 0.00 USD | 0 USD |
| Tuesday, January 31st, 2023 | Turka Laurence A. | officer: Chief Scientific Officer | 18,391 | S-Sale | D | 2,593 | 0.24 USD | 622 USD |
| Sunday, January 29th, 2023 | Turka Laurence A. | officer: Chief Scientific Officer | 14,874 | M-Exempt | D | 7,438 | 0.00 USD | 0 USD |
| Sunday, January 29th, 2023 | Turka Laurence A. | officer: Chief Scientific Officer | 12,359 | M-Exempt | A | 7,438 | 0.00 USD | 0 USD |
| Tuesday, August 9th, 2022 | Appelhans Dannielle | officer: Chief Operating Officer | 37,500 | M-Exempt | D | 12,500 | 0.00 USD | 0 USD |
| Tuesday, August 9th, 2022 | Appelhans Dannielle | officer: Chief Operating Officer | 6,763 | S-Sale | D | 5,737 | 0.80 USD | 4,590 USD |
| Friday, July 29th, 2022 | Schaffert Susanne | director: | 50,000 | A-Award | A | 50,000 | 0.00 USD | 0 USD |
| Tuesday, July 12th, 2022 | Schaffert Susanne | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Thursday, May 12th, 2022 | Prener Anne | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | Prener Anne | director | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | Holles Natalie C. | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | Holles Natalie C. | director | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | Cuss Francis M | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | Cuss Francis M | director | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | Rosenblatt Michael | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | Rosenblatt Michael | director | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | Sohn Catherine A. | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | Sohn Catherine A. | director | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | AFEYAN NOUBAR | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | AFEYAN NOUBAR | director, 10 percent owner: | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | Symonds Jonathan | director: | 25,000 | A-Award | A | 25,000 | 0.00 USD | 0 USD |
| Thursday, May 12th, 2022 | Symonds Jonathan | director | 25,000 | A-Award | A | 25,000 | 1.24 USD | 31,000 USD |
| Thursday, May 12th, 2022 | Epstein David R | director: | 499,762 | A-Award | A | 499,762 | 0.00 USD | 0 USD |
| Thursday, April 21st, 2022 | Epstein David R | director: | 4,720,012 | P-Purchase | A | 30,000 | 1.44 USD | 43,329 USD |
| Friday, December 31st, 2021 | CAGNONI PABLO J | director, officer: CEO and President | 0 | 0 | 0.00 USD | 0 USD | ||
| Monday, January 31st, 2022 | CAGNONI PABLO J | director, officer: CEO and President | 365,000 | A-Award | A | 365,000 | 6.75 USD | 2,463,750 USD |
| Monday, January 31st, 2022 | CAGNONI PABLO J | director, officer: CEO and President | 100,000 | A-Award | A | 100,000 | 0.00 USD | 0 USD |
| Saturday, January 29th, 2022 | CAGNONI PABLO J | director, officer: CEO and President | 63,750 | M-Exempt | D | 21,250 | 0.00 USD | 0 USD |
| Saturday, January 29th, 2022 | CAGNONI PABLO J | director, officer: CEO and President | 42,250 | M-Exempt | A | 21,250 | 0.00 USD | 0 USD |
| Tuesday, February 1st, 2022 | CAGNONI PABLO J | director, officer: CEO and President | 35,520 | S-Sale | D | 6,730 | 6.57 USD | 44,236 USD |
| Monday, January 31st, 2022 | Carmona Jose | officer: Chief Financial Officer | 143,750 | A-Award | A | 143,750 | 6.75 USD | 970,313 USD |
| Monday, January 31st, 2022 | Carmona Jose | officer: Chief Financial Officer | 34,500 | A-Award | A | 34,500 | 0.00 USD | 0 USD |
| Monday, January 31st, 2022 | Appelhans Dannielle | officer: Chief Operating Officer | 125,000 | A-Award | A | 125,000 | 6.75 USD | 843,750 USD |
| Monday, January 31st, 2022 | Appelhans Dannielle | officer: Chief Operating Officer | 30,000 | A-Award | A | 30,000 | 0.00 USD | 0 USD |
| Monday, January 31st, 2022 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 143,750 | A-Award | A | 143,750 | 6.75 USD | 970,313 USD |
| Monday, January 31st, 2022 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 34,500 | A-Award | A | 34,500 | 0.00 USD | 0 USD |
| Saturday, January 29th, 2022 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 24,225 | M-Exempt | D | 8,075 | 0.00 USD | 0 USD |
| Saturday, January 29th, 2022 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 8,075 | M-Exempt | A | 8,075 | 0.00 USD | 0 USD |
| Tuesday, February 1st, 2022 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 5,343 | S-Sale | D | 2,732 | 6.57 USD | 17,957 USD |
| Monday, January 31st, 2022 | Turka Laurence A. | officer: Chief Scientific Officer | 143,750 | A-Award | A | 143,750 | 6.75 USD | 970,313 USD |
| Monday, January 31st, 2022 | Turka Laurence A. | officer: Chief Scientific Officer | 34,500 | A-Award | A | 34,500 | 0.00 USD | 0 USD |
| Saturday, January 29th, 2022 | Turka Laurence A. | officer: Chief Scientific Officer | 22,312 | M-Exempt | D | 7,438 | 0.00 USD | 0 USD |
| Saturday, January 29th, 2022 | Turka Laurence A. | officer: Chief Scientific Officer | 7,438 | M-Exempt | A | 7,438 | 0.00 USD | 0 USD |
| Tuesday, February 1st, 2022 | Turka Laurence A. | officer: Chief Scientific Officer | 4,921 | S-Sale | D | 2,517 | 6.57 USD | 16,544 USD |
| Tuesday, August 31st, 2021 | Appelhans Dannielle | officer: Chief Operating Officer | 150,000 | A-Award | A | 150,000 | 21.72 USD | 3,258,000 USD |
| Tuesday, August 31st, 2021 | Appelhans Dannielle | officer: Chief Operating Officer | 50,000 | A-Award | A | 50,000 | 0.00 USD | 0 USD |
| Monday, August 9th, 2021 | Appelhans Dannielle | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Wednesday, May 12th, 2021 | Epstein David R | director | 27,919 | A-Award | A | 27,919 | 23.25 USD | 649,117 USD |
| Wednesday, May 12th, 2021 | Symonds Jonathan | director | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Wednesday, May 12th, 2021 | AFEYAN NOUBAR | director, 10 percent owner: | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Wednesday, May 12th, 2021 | Sohn Catherine A. | director | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Wednesday, May 12th, 2021 | Rosenblatt Michael | director | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Wednesday, May 12th, 2021 | Cuss Francis M | director | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Wednesday, May 12th, 2021 | Holles Natalie C. | director | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Wednesday, May 12th, 2021 | Prener Anne | director | 25,000 | A-Award | A | 25,000 | 23.25 USD | 581,250 USD |
| Friday, March 19th, 2021 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 15,393,593 | P-Purchase | A | 70,000 | 29.00 USD | 2,030,000 USD |
| Friday, March 19th, 2021 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 5,859,414 | P-Purchase | A | 70,000 | 29.00 USD | 2,030,000 USD |
| Friday, March 19th, 2021 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2,633,703 | P-Purchase | A | 70,000 | 29.00 USD | 2,030,000 USD |
| Monday, March 15th, 2021 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 225,000 | M-Exempt | D | 25,000 | 7.70 USD | 192,500 USD |
| Monday, March 15th, 2021 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 25,000 | M-Exempt | A | 25,000 | 7.70 USD | 192,500 USD |
| Monday, March 15th, 2021 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 0 | S-Sale | D | 25,000 | 20.24 USD | 505,965 USD |
| Thursday, February 11th, 2021 | Epstein David R | director | 4,690,012 | S-Sale | D | 26,704 | 14.93 USD | 398,560 USD |
| Monday, February 8th, 2021 | Epstein David R | director | 4,726,220 | S-Sale | D | 89,233 | 14.88 USD | 1,328,117 USD |
| Tuesday, February 9th, 2021 | Epstein David R | director | 4,724,120 | S-Sale | D | 2,100 | 14.83 USD | 31,146 USD |
| Wednesday, February 10th, 2021 | Epstein David R | director | 4,716,716 | S-Sale | D | 7,404 | 14.79 USD | 109,525 USD |
| Friday, January 29th, 2021 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 142,500 | A-Award | A | 142,500 | 11.97 USD | 1,705,725 USD |
| Friday, January 29th, 2021 | Keson-Brookes Maiken | officer: CLO & Corp. Secretary | 32,300 | A-Award | A | 32,300 | 0.00 USD | 0 USD |
| Friday, January 29th, 2021 | Coughlin Christina M. | officer: Chief Medical Officer | 142,500 | A-Award | A | 142,500 | 11.97 USD | 1,705,725 USD |
| Friday, January 29th, 2021 | Coughlin Christina M. | officer: Chief Medical Officer | 32,300 | A-Award | A | 32,300 | 0.00 USD | 0 USD |
| Friday, January 29th, 2021 | Turka Laurence A. | officer: Chief Scientific Officer | 131,250 | A-Award | A | 131,250 | 11.97 USD | 1,571,063 USD |
| Friday, January 29th, 2021 | Turka Laurence A. | officer: Chief Scientific Officer | 29,750 | A-Award | A | 29,750 | 0.00 USD | 0 USD |
| Friday, January 29th, 2021 | CAGNONI PABLO J | director, officer: CEO and President | 375,000 | A-Award | A | 375,000 | 11.97 USD | 4,488,750 USD |
| Friday, January 29th, 2021 | CAGNONI PABLO J | director, officer: CEO and President | 85,000 | A-Award | A | 85,000 | 0.00 USD | 0 USD |
| Monday, November 30th, 2020 | Carmona Jose | officer: Chief Financial Officer | 400,000 | A-Award | A | 400,000 | 6.27 USD | 2,508,000 USD |
| Thursday, October 1st, 2020 | Carmona Jose | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Thursday, May 21st, 2020 | Holles Natalie C. | director | 25,000 | A-Award | A | 25,000 | 6.22 USD | 155,500 USD |
| Thursday, May 21st, 2020 | Cuss Francis M | director | 25,000 | A-Award | A | 25,000 | 6.22 USD | 155,500 USD |
| Thursday, May 21st, 2020 | Rosenblatt Michael | director | 25,000 | A-Award | A | 25,000 | 6.22 USD | 155,500 USD |
| Thursday, May 21st, 2020 | Sohn Catherine A. | director | 25,000 | A-Award | A | 25,000 | 6.22 USD | 155,500 USD |
| Thursday, May 21st, 2020 | AFEYAN NOUBAR | director, 10 percent owner: | 25,000 | A-Award | A | 25,000 | 6.22 USD | 155,500 USD |
| Thursday, May 21st, 2020 | Symonds Jonathan | director | 25,000 | A-Award | A | 25,000 | 6.22 USD | 155,500 USD |
| Thursday, May 21st, 2020 | Epstein David R | director | 115,771 | A-Award | A | 115,771 | 6.22 USD | 720,096 USD |
| Friday, May 15th, 2020 | OH ANDREW M. | officer: Chief Financial Officer | 755,500 | M-Exempt | D | 5,000 | 4.74 USD | 23,700 USD |
| Friday, May 15th, 2020 | OH ANDREW M. | officer: Chief Financial Officer | 5,000 | M-Exempt | A | 5,000 | 4.74 USD | 23,700 USD |
| Wednesday, April 22nd, 2020 | Coughlin Christina M. | officer: Chief Medical Officer | 19,000 | P-Purchase | A | 19,000 | 5.52 USD | 104,814 USD |
| Tuesday, April 14th, 2020 | CAGNONI PABLO J | director, officer: CEO and President | 21,000 | P-Purchase | A | 21,000 | 4.70 USD | 98,694 USD |
| Tuesday, March 17th, 2020 | Epstein David R | director | 4,815,453 | P-Purchase | A | 5,000 | 3.76 USD | 18,800 USD |
| Friday, March 13th, 2020 | Epstein David R | director | 4,810,453 | P-Purchase | A | 5,000 | 4.00 USD | 20,000 USD |
| Friday, March 13th, 2020 | Epstein David R | director | 4,805,453 | P-Purchase | A | 5,000 | 3.82 USD | 19,100 USD |
